Preoperative Optimization as a Part of Combined Pharmacological and non Pharmacological Treatment Strategy for Patients with Multidrug Resistant Tuberculosis

Fulltext (.pdf)

https://doi.org/10.54937/zs.2022.14.1.12-16

Autori/ Authors: Tomáš Turoček, Eva Rozborilová, Peter Šterbák

In: Zdravotnícke štúdie

ISSN: 1337-723X

Ročník/ Volume: XIV

Číslo/ Issue: 1

Strany/ Page Range: 12-16

Rok vydania/ Publication Year: 2022

Jazyk/ Language: Slovak

Vydavateľ/ Publisher: VERBUM – vydavateľstvo Katolíckej univerzity v Ružomberku

Abstrakt/ Abstract:  Tuberculosis is a communicable infectious disease in majority caused by bacillus Mycobacterium tuberculosis. Lungs are the most often targeted body tissue where infection can spread. Although lung tuberculosis is well curable by combinations of antituberculotic drugs, more serious drug-resistant forms occur. WHO Global Tuberculosis Report provides information about almost half million of new resistant cases and rising multidrug resistant tuberculosis (MDR-TB)  together with serious extensively drug resistant tuberculosis (XDR-TB). Resistant species increase cost of hospitalization and prolong length of stay in hospital. Combination of pharmacological and surgical (non-pharmacological) treatment strategy brings successful tuberculosis cure to certain group of patients. Adequate preoperative optimalization and interdisciplinary approach are essential points of effectual surgical care in combination with pharmacological treatment.

Kľúčové slová/ Keywords: Preoperative optimization. Tuberculosis. Multidrug resistance.

Citácia/ How to cite:

TUROČEK, Tomáš; ROZBORILOVÁ, Eva a ŠTERBÁK, Peter, 2022. Predoperačná optimalizácia pacienta s multirezistentnou formou tuberkulózy pri kombinovanej farmakologickej a nefarmakologickej liečbe. Zdravotnícke štúdie. Online. Roč. XIV, č. 1, s. 12-16. ISSN 1337-723X. Dostupné na: https://doi.org/10.54937/zs.2022.14.1.12-16

Toto dielo je publikované pod/ This work is licensed under a Creative Commons Attribution 4.0 International License.